Obesity and asthma disease phenotypes

Current Opinion in Allergy and Clinical Immunology

Volumn 12, Issue 1, 2012, Pages 76-81

  Stream, Amanda R ^a   Sutherland, E Rand ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

Asthma; Inflammation; Mechanism; Obesity; Steroid

Indexed keywords

ASTHMA; COMORBIDITY; DISEASE ASSOCIATION; DISEASE SEVERITY; HEALTH CARE UTILIZATION; HUMAN; MORBIDITY; OBESITY; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; REVIEW; RISK FACTOR; WEIGHT REDUCTION;

ASTHMA; HUMANS; OBESITY; PHENOTYPE; PREVALENCE; UNITED STATES;

EID: 84857060390     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0b013e32834eca41     Document Type: Review

References (42)

1. Dixon AE, Holguin F, Sood A, et al. An official American Thoracic Society workshop report: obesity and asthma. Proc Am Thorac Soc 2010; 7:325- 335. This statement from the American Thoracic Society was based on combined consensus from experts in the fields of obesity and asthma and reviews the most up-to-date epidemiologic as well as mechanistic studies. Participants concluded that obesity is a major risk factor for asthma for all demographic groups studied, and that it likely represents a new phenotype of asthma.
2. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005; 115:897-909.
3. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of prospective epidemiologic studies. Am J Respir Crit Care Med 2007; 175:661-666. (Pubitemid 46536480)
4. Hjellvik V, Tverdal A, Furu K. Body mass index as predictor for asthma: a cohort study of 118 723 males and females. Eur Respir J 2010; 35:1235-1242. This population-based study was one of the first to evaluate the association between change in BMI over time and the first to demonstrate a positive association in both males and females.
5. Mosen DM, Schatz M, Magid DJ, Camargo CA Jr. The relationship between obesity and asthma severity and control in adults. J Allergy Clin Immunol 2008; 122:507-511; e506.
6. Coogan PF, Palmer JR, O'Connor GT, Rosenberg L. Body mass index and asthma incidence in the Black Women's Health Study. J Allergy Clin Immunol 2009; 123:89-95.
7. Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest 2006; 130:827-833. (Pubitemid 44423616)
8. Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med 2002; 162:1477-1481. (Pubitemid 34747481)
9. Nicolacakis K, Skowronski ME, Coreno AJ, et al. Observations on the physiological interactions between obesity and asthma. J Appl Physiol 2008; 105:1533-1541.
10. Litonjua AA, Sparrow D, Celedon JC, et al. Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the Normative Aging Study. Thorax 2002; 57:581-585. (Pubitemid 34761758)
11. Chapman DG, Berend N, King GG, Salome CM. Increased airway closure is a determinant of airway hyperresponsiveness. Eur Respir J 2008; 32:1563-1569.
12. Sutherland TJ, Cowan JO, Taylor DR. Dynamic hyperinflation with bronchoconstriction: differences between obese and nonobese women with asthma. Am J Respir Crit Care Med 2008; 177:970-975. (Pubitemid 351717590)
13. Vortmann M, Eisner MD. BMI and health status among adults with asthma. Obesity 2008; 16:146-152. (Pubitemid 351271964)
14. Haldar P, Pavord ID, Shaw DE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178:218-224.
15. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010; 181:315-323. Another cluster analysis of a large cohort of patients from the Severe Asthma Research Program also identified a unique cluster of obese individuals with later onset disease and worse control based on oral corticosteroid use supporting the concept of obese asthma as a distinct clinical phenotype.
16. Taylor B, Mannino D, Brown C, et al. Body mass index and asthma severity in the National Asthma Survey. Thorax 2008; 63:14-20.
17. Peters JI, McKinney JM, Smith B, et al. Impact of obesity in asthma: evidence from a large prospective disease management study. Ann Allergy Asthma Immunol 2011; 106:30-35. This prospective randomized, controlled trial of asthma management over 1 year did not show worsened asthma outcomes in either adults or children with obesity except for significantly reduced disease specific QoL in class III obesity.
18. Haselkorn T, Fish JE, Chipps BE, et al. Effect of weight change on asthma related health outcomes in patients with severe or difficult-to-treat asthma. Respir Med 2009; 103:274-283.
19. Lessard A, Turcotte H, Cormier Y, Boulet LP. Obesity and asthma: a specific phenotype? Chest 2008; 134:317-323.
20. Todd DC, Armstrong S, D'Silva L, et al. Effect of obesity on airway inflammation: a cross-sectional analysis of body mass index and sputum cell counts. Clin Exp Allergy 2007; 37:1049-1054. (Pubitemid 46957461)
21. McLachlan CR, Poulton R, Car G, et al. Adiposity, asthma, and airway inflammation. J Allergy Clin Immunol 2007; 119:634-639.
22. Peters-Golden M, Swern A, Bird SS, et al. Influence of body mass index on the response to asthma controller agents. Eur Respir 2006; 27:495-503. (Pubitemid 43372522)
23. Sutherland ER, Camargo CA Jr, Busse WW, et al. Comparative effect of body mass index on response to asthma controller therapy. Allergy Asthma Proc 2010; 31:20-25. This study demonstrated that ICSs were superior to leukotriene modifiers across all BMI categories.
24. Boulet LP, Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir Med 2007; 101:2240-2247. (Pubitemid 47471412)
25. Farah CS, Kermode JA, Downie SR, et al. Obesity is a determinant of asthma control independent of inflammation and lung mechanics. Chest 2011; 140:659-666. This recent study evaluating asthma control test scores and physiology measures of disease severity before and after ICS therapy demonstrated that asthma control was dependent on BMI independent of lung function and airway inflammation.
26. Sutherland ER, Goleva E, Strand M, et al. Body mass and glucocorticoid response in asthma. Am J Respir Crit Care Med 2008; 178:682-687.
27. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007; 117:175-184. (Pubitemid 46048464)
28. Curat CA, Miranville A, Sengenes C, et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53:1285-1292. (Pubitemid 38569015)
29. Lumeng CN, DelProposto JB, Westcott DJ, Saltiel AR. Phenotypic switching of adipose tissue macrophages with obesity is generated by spatiotemporal differences in macrophage subtypes. Diabetes 2008; 57:3239-3246.
30. Sood A, Ford ES, Camargo CA Jr. Association between leptin and asthma in adults. Thorax 2006; 61:300-305.
31. Sood A, Cui X, Qualls C, et al. Association between asthma and serum adiponectin concentration in women. Thorax 2008; 63:877-882.
32. Shore SA. Obesity, airway hyperresponsiveness, and inflammation. J Appl Physiol 2010; 108:735-743. This extensive review on the role of adipokines and obesity summarizes both animal and human data to date.
33. Sood A, Qualls C, Arynchyn A, et al. Obesity-asthma association: is it explained by systemic oxidant stress? Chest 2009; 136:1055-1062.
34. Holguin F, Fitzpatrick A. Obesity, asthma, and oxidative stress. J Appl Physiol 2010; 108:754-759. This study failed to demonstrate significant association between markers of airway and systemic oxidative stress in either obese or lean asthmatic individuals.
35. Chan WW, Chiou E, Obstein KL, et al. The efficacy of proton pump inhibitors for the treatment of asthma in adults: a meta-analysis. Arch Intern Med 2011; 171:620-629.
36. Kiljander TO, Junghard O, Beckman O, Lind T. Effect of esomeprazole 40 mg once or twice daily on asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2010; 181:1042-1048. This study supported the use of proton pump inhibitors in asthmatic patients with symptomatic comorbid reflux disease, but did not report significant improvements in asthma disease control in which reflux was adequately treated, arguing against GERD as a significant confounder in the obesity asthma association.
37. Teodorescu M, Polomis DA, Hall SV, et al. Association of obstructive sleep apnea risk with asthma control in adults. Chest 2010; 138:543-550. This is an important preliminary study, suggesting that undiagnosed obstructive sleep apnea may be a mediator in the obesity-asthma association and contribute to poor asthma control in obese individuals.
38. Hakala K, Stenius-Aarniala B, Sovijarvi A. Effects of weight loss on peak flow variability, airways obstruction, and lung volumes in obese patients with asthma. Chest 2000; 118:1315-1321.
39. Aaron SD, Fergusson D, Dent R, et al. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004; 125:2046-2052. (Pubitemid 38788168)
40. Stenius-Aarniala B, Poussa T, Kvarnstrom J, et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. BMJ 2000; 320:827-832. (Pubitemid 30175861)
41. Thomas PS, Cowen ER, Hulands G, Milledge JS. Respiratory function in the morbidly obese before and after weight loss. Thorax 1989; 44:382-386. (Pubitemid 19143945)
42. Weiner P, Waizman J, Weiner M, et al. Influence of excessive weight loss after gastroplasty for morbid obesity on respiratory muscle performance. Thorax 1998; 53:39-42. (Pubitemid 28178974)